@article {2108, title = {Decreased Expression of Endocrine Glands Vascular Endothelial Growth Factor (EG-VEGF) in Rat Endometrial After Stimulation with Recombinants FSH Can be Reduce Implantation Rates}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {October 2023}, pages = {707-713}, type = {Original Article}, chapter = {707}, abstract = {

Background: Decreased expression of EG-VEGF in human endometrium after administration of ovarian stimulators has been reported to adversely affect endometrial receptivity and low implantation rates. Objective: To determine the effect of recombinant FSH administration on EG-VEGF protein in the endometrium of rats taken in the secretory phase and how it relates to endometrial receptivity. Design: A total of 36 female wistar rats with normal estrous cycles were randomly assigned to the natural cycle group (NC) and two stimulation groups (SC) which were injected with recombinant FSH at 12.5 IU and 25 IU intraperitoneally. Uterine necropsy and blood collection were performed on day 1, day 2, and day 3 after hCG administration. A total of 3 female rats from each group were mated with male rats (two males and three females in one cage). A successful marriage is indicated by the presence of a vaginal plug the next day. The level of EG-VEGF protein expression was assessed by immunohistochemical technique and steroid hormone levels were measured by the Elisa technique. Results: ANOVA test, that the expression of EG-VEGF in the endometrial glands showed a significant decrease from the normal cycle group to the stimulated cycle group 1 (SC 1) and SC2 (P = 0.00), as well as the expression of EG-VEGF in the endometrial stroma. (P = 000). Steroid hormone levels did not show a significant decrease between the normal cycle group and the stimulated cycle group (P = 0.48 and P = 0.13). Conclusion: Decreased EG-VEGF expression in rat endometrium after administration of recombinant FSH is associated with decreased endometrial receptivity which can reduce pregnancy rates.

}, keywords = {EG-VEGF, Endometrial receptivity, rFSH, Secretory phase.}, doi = {10.5530/pj.2023.15.141}, author = {Raden Muharam and Nurhuda Sahar and Kusmardi Kusmardi and Luluk Yunaini and Risqa Novita and Rosalina Thuffi and Conny Riana Tjampakasari and Ponco Birowo and Diyah Kristanty} } @article {1858, title = {Analysis of LH Receptor Expression in the Testes of Infertile Azoospermic Non-Obstructive (NOA) Men at High Serum Prolactin Concentrations}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {October 2022}, pages = {462-468}, type = {Original Article}, chapter = {462}, abstract = {

Background: Hyperprolactin is one of the endocrine disorders that causes male infertility (11\%). The mechanism is not widely known; it is thought to occur through disruption of LH receptor activity on germ cells. Objective: The aim of study to compare the level of prolactin secretion with receptor expression in non-azoospermic infertile men (NOA). Methods: During the period from July 2019 to July 2021, 40 samples of testicular tissue and serum were obtained from infertile NOA men, aged 25-50 years who were recruited from Ciptomangunkusumo Hospital (RSCM) Jakarta, Faculty of Medicine, Universitas Indonesia and Bunda Hospital Jakarta. Subjects were divided into 4 groups based on prolactin levels (20 ng/ml, 20-50 ng/ml, 50-100 ng/ml and 100ng/ml). This group was tested for significance between groups and continued with a correlation test with the level of LH receptor expression. Results: ANOVA test showed a significant decrease in LH receptor expression between prolactin levels \< 20 ng/mL with levels of 50-100 ng/ml and prolactin levels \> 100 ng/ml (P \< 0.05). Furthermore, the results of the correlation test showed a significant decrease between prolactin levels and LH receptor expression (P \< 0.05). Conclusion: The higher the level of prolactin secretion in this sample, there is a decrease in LH receptor expression, so that testosterone production decreases and the spermatogenesis process will be disrupted.

}, keywords = {Hyperprolactinemia, LH receptor expression, Male infertility, Non obstructive azoospermia (NOA).}, doi = {10.5530/pj.2022.14.123}, author = {Ponco Birowo and Nurhuda Sahar and R. Muharam and Dwi Ari Pujianto and Rosalina Thuffi and Kusmardi Kusmardi and Conny Riana Tjempakasari} }